GLP-1 Reduces appetite, slows gastric emptying GIP Enhances insulin, improves fat metabolism Glucagon Increases energy expenditure, burns fat Based on Phase 2 clinical trial data (published in NEJM, 2023), retatrutide's side effects are primarily gastrointestinal, similar to other GLP-1 agonists but with some differences due to the glucagon component
Latest Articles
Among the additional cardiovascular outcomes, only incident peripheral vascular disease or atherosclerosis reached nominal significance across weight loss strata ( P = 0.033
*Dng vin ung* Ung mt ln mi ngy vo bui sng khi bng i, km theo mt ly nc c dung tch ti thiu 120 ml
WHAT YOU'LL PAY Cost & Alternatives for Medicare Beneficiaries Savings Card Not Available for Medicare Medicare beneficiaries cannot use the Zepbound Savings Card
Effective Weight Loss One of the standout benefits of semaglutide is its proven effectiveness in promoting weight loss